KalVista sets June 18, 2026 as annual meeting date; stockholder deadlines revised

KalVista Pharmaceuticals, Inc.

2026 Annual Meeting set for June 18, 2026; changed >30 days from 2025 meeting.
Stockholder proposals for proxy inclusion due January 6, 2026.
Other proposals or director nominations due August 31, 2025 (10 days after this 8-K).
Universal proxy rule compliance required for soliciting proxies in support of non-company nominees.
Advance notice procedures per Bylaws apply; notice to Cambridge, MA address.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.